BarryW.GoyMD

Physician

Dr. Goy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 1994 - 1998
Kaiser Permanente Southern California (Los Angeles)Internship, Internal Medicine, 1992 - 1993
David Geffen School of Medicine at UCLAClass of 1992

PubMed

29 citations
Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer
Barry W. Goy, Raoul J. Burchette, Margaret S. Soper, Tangel Chang, H. Cosmatos
Urology. 2020-02-01
106 citations
The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors
Barry W. Goy, Steve P. Lee, Frederick R. Eilber, Fred Dorey, Jeffrey J. Eckardt
International Journal of Radiation Oncology, Biology, Physics. 1996-01-01
5 citations
The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
Barry W. Goy, Sajjad P Syed, Aswini Padmanabhan, Raoul J. Burchette, Chris S. Helmstedter
Radiotherapy and Oncology. 2021-11-07

Lectures

Ten year treatment complication outcomes of radical prostatectomy versus external beam radiation therapy versus brachytherapy for 1,503 patients with intermediate risk...
2019 ASCO Annual Meeting - 6/1/2019

Intermediate-Risk PCa: Urinary Complications Lowest with BrachytherapyApril 8th, 2019